◆
BLACKSPECTER
AI Chat öffnen →
BlackSpecter
›
Aktien
›
AZN
AZN
(AZN)
Kennzahlen
Marktkapitalisierung
n/a
KGV (TTM)
n/a
Umsatz (TTM)
n/a
EBITDA
n/a
Dividendenrendite
n/a
52W Hoch
n/a
52W Tief
n/a
Beta
n/a
EPS (TTM)
n/a
Forward KGV
n/a
PEG Ratio
n/a
Short-Quote
n/a
Analysten-Ratings
Keine Analysten-Daten verfügbar
Earnings
Keine Earnings-Daten verfügbar
Aktuelle News
Business Wire
·
vor 6 Min.
Kairos Pharma Reports Breakthrough Interim Safety Data in Phase 1 Trial of ENV-105 in EGFR-Mutated Lung Cancer Patients — Targeting a $10 Billion Drug Resistance Market
Bloomberg
·
vor 2 Std.
Eli Lilly-Backed Novel Cancer Therapy Firm Raises $315 Million
Simply Wall St.
·
vor 7 Std.
AstraZeneca (LSE:AZN) Stock Could Trade At A 46% Discount After Wainua Setback
Morningstar Research
·
vor 12 Std.
Analyst Report: Ionis Pharmaceuticals, Inc.
Pharmaceutical Technology
·
vor 21 Std.
AstraZeneca pays up to $1.5bn to license Dizal Pharma’s lung cancer drug
Zacks
·
vor 22 Std.
Here's How Pfizer's Oncology Growth Story Looks Ahead of Q2 Results
Frag BlackSpecter AI über AZN
Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.
Ist AZN kaufenswert?
AZN Earnings Analyse
AZN Bewertung
AI Chat öffnen →